StonvexLoading…
StonvexStonvexStonvexCore line items from MCD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $26.89B | $25.92B | $25.49B | $23.18B |
Operating Income | $12.39B | $11.71B | $11.65B | $9.37B |
Net Income | $8.56B | $8.22B | $8.47B | $6.18B |
EPS (Diluted) | $11.95 | $11.39 | $11.56 | $8.33 |
Total Assets | $59.52B | $55.18B | $56.15B | $50.44B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $774.00M | $1.08B | $4.58B | $2.58B |
Free Cash Flow OCF − CapEx | $7.19B | $6.67B | $7.25B | $5.49B |
Shares Outstanding | 716.4 | 721.9 | 732.3 | 741.3 |